Cargando…
Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes
Background: Immune checkpoint blockade (ICB) represents a promising treatment for cancer, but predictive biomarkers are needed. We aimed to develop a cost-effective signature to predict immunotherapy benefits across cancers. Methods: We proposed a study framework to construct the signature. Specific...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459043/ https://www.ncbi.nlm.nih.gov/pubmed/36092890 http://dx.doi.org/10.3389/fgene.2022.917118 |